跳至主要内容
临床试验/NL-OMON54833
NL-OMON54833已完成不适用

A Prospective Multicenter Longitudinal Cohort Study of the mymobility Platform - mymobility clinical study

Zimmer Biomet Nederland bv0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subject must be 18 years of age or older.
  • Subject is indicated for a primary, unilateral total or partial knee
  • arthroplasty, or total hip arthroplasty based on a physical exam.
  • Investigator plans to treat subject with a Zimmer Biomet device as part of
  • their clinical care.
  • Subject must own and maintain an iPhone 6 or newer (excluding the iPhone SE).
  • Subject is mobile with no more than a single cane/single crutch assist.

排除标准

  • Subject is a current alcohol or drug abuser. • Subject has inflammatory
  • arthropathies which would interfere or compromise the activity profiles within
  • this study. • Subject is considered a member of a protected population (e.g.,
  • prisoner, mentally incompetent, etc.). • Subject is currently participating in
  • any other surgical intervention, physical therapy or pain management study
  • which would compromise the results of this study. • Subject requires
  • simultaneous or staged bilateral replacements, staged <90 days apart.
  • Subjects can be enrolled into the study for the second, staged arthroplasty if
  • scheduled >89 days after their first, contralateral replacement.

研究者

发起方
Zimmer Biomet Nederland bv

相似试验